BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28199919)

  • 1. Relationships between oral MUC1 expression and salivary hormones in burning mouth syndrome.
    Kang JH; Kim YY; Chang JY; Kho HS
    Arch Oral Biol; 2017 Jun; 78():58-64. PubMed ID: 28199919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in oral mucosal MUC1 expression and salivary hormones throughout the menstrual cycle.
    Lee YH; Kim YY; Chang JY; Kho HS
    Oral Dis; 2015 Nov; 21(8):962-8. PubMed ID: 26332504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary cortisol, 17β-estradiol, progesterone, dehydroepiandrosterone, and α-amylase in patients with burning mouth syndrome.
    Kim HI; Kim YY; Chang JY; Ko JY; Kho HS
    Oral Dis; 2012 Sep; 18(6):613-20. PubMed ID: 22533537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC1 and Toll-like receptor-2 expression in burning mouth syndrome and oral lichen planus.
    Kho HS; Chang JY; Kim YY; Kim Y
    Arch Oral Biol; 2013 Jul; 58(7):837-42. PubMed ID: 23411403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Analysis of Psychological, Hormonal, and Genetic Factors Between Burning Mouth Syndrome and Secondary Oral Burning.
    das Neves de Araújo Lima E; Barbosa NG; Dos Santos AC; AraújoMouraLemos TM; de Souza CM; Trevilatto PC; da Silveira EJ; de Medeiros AM
    Pain Med; 2016 Sep; 17(9):1602-11. PubMed ID: 26849950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiorphin in burning mouth syndrome patients: a case-control study.
    Salarić I; Sabalić M; Alajbeg I
    Clin Oral Investig; 2017 Sep; 21(7):2363-2370. PubMed ID: 28013436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary levels of IL-1beta, IL-6, IL-8, and TNF-alpha in patients with burning mouth syndrome.
    Suh KI; Kim YK; Kho HS
    Arch Oral Biol; 2009 Sep; 54(9):797-802. PubMed ID: 19555923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiety and salivary cortisol levels in patients with burning mouth syndrome: case-control study.
    Amenábar JM; Pawlowski J; Hilgert JB; Hugo FN; Bandeira D; Lhüller F; Lopes de Souza MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):460-5. PubMed ID: 18329582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Salivary Cortisol and α-amylase Levels and Psychological Profiles in Patients with Burning Mouth Syndrome.
    Nosratzehi T; Salimi S; Parvaee A
    Spec Care Dentist; 2017 May; 37(3):120-125. PubMed ID: 28112423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary dehydroepiandrosterone (DHEA) levels in patients with the complaint of burning mouth: a case-control study.
    Dias Fernandes CS; Salum FG; Bandeira D; Pawlowski J; Luz C; Cherubini K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Oct; 108(4):537-43. PubMed ID: 19778740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between burning mouth syndrome patients with and without psychological problems.
    Kim MJ; Kim J; Kho HS
    Int J Oral Maxillofac Surg; 2018 Jul; 47(7):879-887. PubMed ID: 29506949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineral and trace element analysis of saliva from patients with BMS: a cross-sectional prospective controlled clinical study.
    López-Jornet P; Juan H; Alvaro PF
    J Oral Pathol Med; 2014 Feb; 43(2):111-6. PubMed ID: 23869755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary cortisol, stress and quality of life in patients with burning mouth syndrome.
    López-Jornet P; Camacho-Alonso F; Andujar-Mateos MP
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1212-3. PubMed ID: 19453816
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of salivary oxidate stress biomarkers, nitric oxide and C-reactive protein in patients with oral lichen planus and burning mouth syndrome.
    Tvarijonaviciute A; Aznar-Cayuela C; Rubio CP; Ceron JJ; López-Jornet P
    J Oral Pathol Med; 2017 May; 46(5):387-392. PubMed ID: 27862315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saliva on the oral mucosa and whole saliva in women diagnosed with burning mouth syndrome.
    Acharya S; Hägglin C; Jontell M; Wenneberg B; Ekström J; Carlén A
    Oral Dis; 2018 Nov; 24(8):1468-1476. PubMed ID: 29917294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of salivary cortisol and psychological factors in patients with oral lichen planus.
    Shah B; Ashok L; Sujatha GP
    Indian J Dent Res; 2009; 20(3):288-92. PubMed ID: 19884710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burning mouth syndrome: a therapeutic approach involving mechanical salivary stimulation.
    de Souza FT; Amaral TM; dos Santos TP; Abdo EN; Aguiar MC; Teixeira AL; Kummer AM; Abreu MH; Silva TA
    Headache; 2012 Jun; 52(6):1026-34. PubMed ID: 22084903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral epithelial MUC1 and oral health.
    Kho HS
    Oral Dis; 2018 Mar; 24(1-2):19-21. PubMed ID: 29480594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic changes of saliva and taste in burning mouth syndrome patients.
    Imura H; Shimada M; Yamazaki Y; Sugimoto K
    J Oral Pathol Med; 2016 Mar; 45(3):231-6. PubMed ID: 26293497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome predictors of initial treatment with topical lubricant and parafunctional habit control in burning mouth syndrome (BMS).
    Ko JY; Park IH; Park HK; Kho HS
    Arch Gerontol Geriatr; 2011; 53(3):263-9. PubMed ID: 21075463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.